Skip to main content
. Author manuscript; available in PMC: 2015 Jun 22.
Published in final edited form as: J Neurosci Res. 2010 Mar;88(4):746–757. doi: 10.1002/jnr.22253

TABLE I.

FasL Effects on Anti-apoptotic Gene ExpressionϮ

Anti-apoptosis gene Fold up- or down-regulation
(FasL NPC/control NPC)
Akt1 1.07
Api5 1.05
Ataf −1.19
Bag1 −1.15
Bag3 −1
Bcl2 1.27
Bcl2l1 −1.15
Bcl2l2 −1.08
Birc1a 1.15
Birc1b 1.07
Birc2 1.07
Birc3 7.19**
Birc4 1.14
Birc5 1.03
Bnip3 1.05
Casp2 −1.25
Cflar 1.49
Dad1 2.06*
Tsc22d3 1.01
Hells 1.52
Il01 1.69
Lhx4 −1.29
Mcl1 −1.02
Nfkb1 1.02
Nme5 1.09
Pax7 1.21
Pim2 1.19
Polb 1.02
Prdx2 −1.15
Rnf7 −1.02
Sphk2 1.01
Tnf −1.03
Cd40lg 1.08
Zc3hc 1.12
Ϯ

Results from mouse apoptosis gene array analysis. RNA was extracted from NPC control and FasL (200 ng/ml)-treated cells grown in minimal medium for 48 hr. Among all the antiapoptotic genes tested, Birc3 was the only one that showed a significant change in mRNA expression with FasL treatment. -Fold differences and P values obtained from averaging three separate arrays. Positive numbers indicate up-regulation; negative numbers indicate down-regulation. -Fold difference obtained with the equation (2−ΔCt FasL)/(2−ΔCt control)

*

P < 0.05

**

P < 0.00001